Skip to content

The diagnostic value and clinical application of noninvasive preimplantation genetic testing in mosaic embryos

The diagnostic value and clinical application of noninvasive preimplantation genetic testing in mosaic embryos

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033020
Enrollment
Unknown
Registered
2020-05-18
Start date
2020-05-12
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mosaic embryos

Interventions

Gold Standard:The copy number of chromosomes in the inner cell mass for preimplantation genetic testing
Index test:The&#32
of&#32
in&#32
the&#32
blastocyst&#32
for&#32
preimplantation&#32
testing.

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 39 Years

Inclusion criteria

Inclusion criteria: Patients pursued preimplantation genetic testing (including PGS and PGD) at Reproductive Medicine Center of the First Affiliated Hospital of Anhui Medical University from 2018 to 2019 with mosaic embryos in the test results.

Exclusion criteria

Exclusion criteria: Patients with mosaic embryos involved 5 or more chromosomes or were unwilling to participate in this study.

Design outcomes

Primary

MeasureTime frame
chromosomal copy number;

Countries

China

Contacts

Public ContactPing Zhou

Reproductive Medicine Center, the First Affiliated Hospital of Anhui Medical University

zhoup_325@aliyun.com+86 13965042605

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026